Published in Catheter Cardiovasc Interv on June 07, 2011
Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol (2011) 1.22
Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review. J Cardiothorac Surg (2013) 0.99
A systematic review of transapical aortic valve implantation. Ann Cardiothorac Surg (2012) 0.84
How to adapt the implantation technique for the new SAPIEN 3 transcatheter heart valve design. J Interv Cardiol (2014) 0.81
Learning curves for transapical transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance, success, and safety. J Thorac Cardiovasc Surg (2016) 0.81
Aortic regurgitation after transcatheter aortic valve implantation: mechanisms and implications. Cardiovasc Diagn Ther (2013) 0.81
Challenges in cardiac device innovation: is neuroimaging an appropriate endpoint? Consensus from the 2013 Yale-UCL Cardiac Device Innovation Summit. BMC Med (2013) 0.80
Early and intermediate survival after transcatheter aortic valve implantation: systematic review and meta-analysis of 14 studies. BMJ Open (2013) 0.79
Initial experience of two national centers in transcatheter aortic prosthesis implantation. Arq Bras Cardiol (2014) 0.78
The role of balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation. Kardiochir Torakochirurgia Pol (2015) 0.77
Mid-term results of 150 TAVI comparing apical versus femoral approaches. J Cardiothorac Surg (2015) 0.76
Transcatheter aortic valve implantation. Glob Cardiol Sci Pract (2012) 0.75
Nucleotide Catabolism on the Surface of Aortic Valve Xenografts; Effects of Different Decellularization Strategies. J Cardiovasc Transl Res (2016) 0.75
Transapical transcatheter aortic valve implantation: the front door approach captures the world. Cardiovasc Diagn Ther (2012) 0.75
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency. Open Heart (2016) 0.75
The Edwards SAPIEN Transcatheter Heart Valve for Calcific Aortic Stenosis: A Review of the Valve, Procedure, and Current Literature. Cardiol Ther (2012) 0.75
Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation. Am Heart J (2016) 0.75
Recent advances in transcatheter aortic valve implantation: novel devices and potential shortcomings. Curr Cardiol Rev (2013) 0.75
Multidisciplinary team approach for identifying potential candidate for transcatheter aortic valve implantation. Yonsei Med J (2014) 0.75
Is proctoring mandatory when starting a TAVI program? Ann Cardiothorac Surg (2012) 0.75
Learning curve for transcatheter aortic valve replacement. Catheter Cardiovasc Interv (2011) 0.75
Transcatheter aortic valve implantation: early experience in Korea. Korean Circ J (2012) 0.75
A prospective, non-randomized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis. Am J Cardiovasc Dis (2014) 0.75
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04
Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med (2011) 15.70
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell (2000) 8.29
Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med (2012) 6.27
Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol (2010) 5.09
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47
Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation (2006) 3.94
Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation (2010) 3.65
Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation (2007) 3.44
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37
Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol Cell (1997) 3.29
Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation (2006) 2.88
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. JACC Cardiovasc Interv (2013) 2.75
Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation (2011) 2.72
A high phase-space-density gas of polar molecules. Science (2008) 2.61
Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg (2006) 2.61
Direct splitting of water under visible light irradiation with an oxide semiconductor photocatalyst. Nature (2001) 2.38
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA (2006) 2.35
Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv (2006) 2.34
Management of vascular access in transcatheter aortic valve replacement: part 1: basic anatomy, imaging, sheaths, wires, and access routes. JACC Cardiovasc Interv (2013) 2.20
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation (2004) 2.16
Quantum-state controlled chemical reactions of ultracold potassium-rubidium molecules. Science (2010) 2.15
Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004). J Am Coll Cardiol (2007) 2.11
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses. Catheter Cardiovasc Interv (2011) 2.06
Hospital-based surveillance of invasive pneumococcal disease and pneumonia in South Bangalore, India. Indian Pediatr (2015) 2.06
Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol (2009) 2.05
Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol (2011) 2.02
Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation (2009) 2.00
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99
Prevention and management of transcatheter balloon-expandable aortic valve malposition. Catheter Cardiovasc Interv (2008) 1.98
Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean population. Hum Genet (2003) 1.97
Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J Lipid Res (1999) 1.92
Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg (2006) 1.91
Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging (2008) 1.91
Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). JACC Cardiovasc Interv (2011) 1.88
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation (2012) 1.87
Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J (2008) 1.86
Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc Imaging (2008) 1.82
Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc Natl Acad Sci U S A (1991) 1.81
Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J (2009) 1.81
Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation (2011) 1.79
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol (2004) 1.77
PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene (2010) 1.77
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72
The role of intramuscular lipid in insulin resistance. Acta Physiol Scand (2003) 1.70
Primary percutaneous balloon pericardiotomy for malignant pericardial effusion. Catheter Cardiovasc Interv (2008) 1.69
Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development (1999) 1.69
Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation (2012) 1.66
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study. JACC Cardiovasc Interv (2008) 1.63
Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA. Vaccine (1999) 1.61
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol (2012) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv (2010) 1.60
Transatrial transcatheter tricuspid valve-in-valve implantation of balloon expandable bioprosthesis. Ann Thorac Surg (2010) 1.57
Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv (2009) 1.53
Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene. J Immunol (1994) 1.52
Image registration via level-set motion: applications to atlas-based segmentation. Med Image Anal (2003) 1.52
Current status of transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 1.52
Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol (1997) 1.51
Stenting for coronary artery spasm. Catheter Cardiovasc Interv (2002) 1.50
Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial. J Am Coll Cardiol (2009) 1.50
Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings. J Med Econ (2013) 1.48
Multidetector computed tomography in transcatheter aortic valve implantation. JACC Cardiovasc Imaging (2011) 1.47
Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation (2013) 1.47
A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J (2010) 1.46
Cholesterol movement in Niemann-Pick type C cells and in cells treated with amphiphiles. J Biol Chem (2000) 1.45
Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. JACC Cardiovasc Interv (2012) 1.45